Font Size
A
A
A

Estrogen and Progesterone Receptor Tests


Estrogen and progesterone receptor (ER/PR) tests identify whether hormones affect the way that breast cancer grows. The results of these tests help doctors decide whether to use hormone therapy to help stop the cancer from growing.

The hormones estrogen and progesterone attach to certain receptors on the breast cells to stimulate the growth of normal breast cells and some breast cancers.

Breast cancer cells that lack these receptors (ER-negative and PR-negative cancers) are much less likely to respond to treatment with such medicines as tamoxifen or aromatase inhibitors. ER/PR-positive tumors have these receptors and are more likely to respond to treatment with tamoxifen or aromatase inhibitors.

ByHealthwise Staff
Primary Medical ReviewerSarah Marshall, MD - Family Medicine
Specialist Medical ReviewerDouglas A. Stewart, MD - Medical Oncology
Last RevisedMay 14, 2012

eMedicineHealth Medical Reference from Healthwise

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit Healthwise.org

© 1995-2014 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.



NIH talks about Ebola on WebMD


Medical Dictionary